Acute toxicity study |
100 mg/kg b.wt. (1 dose) |
Intraperitoneal |
Mouse; males (n = 3) |
Negative |
|
1000 mg/kg b.wt. (1 dose) |
Intraperitoneal |
Mouse; males (n = 3) |
Negative |
Acute toxicity study |
2000 mg/kg b.wt. (1 dose) |
Oral |
Rat; males (n = 5) and females (n = 5) |
Negative |
Bacterial mutation assay |
0.586–18.8 µg/plate |
In vitro |
Salmonella typhimurium andEscherichia coli
|
Negative in both species |
Mammalian erythrocyte micronucleus test |
500, 1000, and 2000 mg/kg b.wt. (1 dose) |
Oral |
Mouse; males (n = 5) and females (n = 5) |
Negative in all three dosings |
Mammalian chromosome aberration test |
6.25–100 µg/ml |
In vitro |
CHO cells |
Negative in inducing numerical chromosome aberrations; positive in inducing structural chromosome aberrations |
29-Day subchronic toxicity study |
50 mg/kg b.wt. every day for 29 days |
Oral |
Rat; male (n = 10) and female (n = 10) |
Negative in female; positive in male |